Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Tuberculosis | Research

Epidemiology of recurrent pulmonary tuberculosis by bacteriological features of 100 million residents in China

Authors: Hui Jiang, Jinfeng Yin, Fangchao Liu, Yuxia Yao, Chao Cai, Jiying Xu, Lijun Zheng, Chendi Zhu, Junnan Jia, Xu Gao, Wangli Xu, Weimin Li, Guolong Zhang

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Recurrence continues to place significant burden on patients and tuberculosis programmes worldwide, and previous studies have rarely provided analysis in negative recurrence cases. We characterized the epidemiological features of recurrent pulmonary tuberculosis (PTB) patients, estimated its probability associated with different bacteriology results and risk factors.

Methods

Using 2005–2018 provincial surveillance data from Henan, China, where the permanent population approximately were 100 million, we described the epidemiological and bacteriological features of recurrent PTB. The Kaplan–Meier method and Cox proportional hazard models, respectively, were used to estimate probability of recurrent PTB and risk factors.

Results

A total of 7143 (1.5%) PTB patients had recurrence, and of 21.1% were bacteriological positive on both laboratory tests (positive–positive), and of 34.9% were negative–negative. Compared with bacteriological negative recurrent PTB at first episodes, the bacteriological positive cases were more male (81.70% vs 72.79%; P < 0.001), higher mortality risk (1.78% vs 0.92%; P = 0.003), lower proportion of cured or completed treatment (82.81% vs 84.97%; P = 0.022), and longer time from onset to end-of-treatment. The probability of recurrence was higher in bacteriological positive cases than those in bacteriological negative cases (0.5% vs 0.4% at 20 months; P < 0.05).

Conclusions

Based on patient’s epidemiological characteristics and bacteriological type, it was necessary to actively enact measures to control their recurrent.
Appendix
Available only for authorised users
Literature
2.
go back to reference Romanowski K, Balshaw RF, Benedetti A, et al. Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis. Thorax. 2019;74(3):291–7.CrossRef Romanowski K, Balshaw RF, Benedetti A, et al. Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis. Thorax. 2019;74(3):291–7.CrossRef
3.
go back to reference Colangeli R, Jedrey H, Kim S, et al. Bacteriological factors that predict relapse after tuberculosis therapy. N Engl J Med. 2018;379(9):823–33.CrossRef Colangeli R, Jedrey H, Kim S, et al. Bacteriological factors that predict relapse after tuberculosis therapy. N Engl J Med. 2018;379(9):823–33.CrossRef
4.
go back to reference Zong Z, Huo F, Shi J, et al. Relapse versus reinfection of recurrent tuberculosis patients in a national tuberculosis specialized hospital in Beijing, China. Front Microbiol. 2018;9:1858.CrossRef Zong Z, Huo F, Shi J, et al. Relapse versus reinfection of recurrent tuberculosis patients in a national tuberculosis specialized hospital in Beijing, China. Front Microbiol. 2018;9:1858.CrossRef
5.
go back to reference Shen X, Yang C, Wu J, et al. Recurrent tuberculosis in an urban area in China: relapse or exogenous reinfection? Tuberculosis. 2017;103:97.CrossRef Shen X, Yang C, Wu J, et al. Recurrent tuberculosis in an urban area in China: relapse or exogenous reinfection? Tuberculosis. 2017;103:97.CrossRef
6.
go back to reference Liu Y, Zhang X, Yu J, et al. Tuberculosis relapse is more common than reinfection in Beijing, China. Infect Dis. 2020;52(12):858–65.CrossRef Liu Y, Zhang X, Yu J, et al. Tuberculosis relapse is more common than reinfection in Beijing, China. Infect Dis. 2020;52(12):858–65.CrossRef
7.
go back to reference Crofts JP, Andrews NJ, Barker RD, et al. Risk factors for recurrent tuberculosis in England and Wales, 1998–2005. Thorax. 2010;65(4):310–4.CrossRef Crofts JP, Andrews NJ, Barker RD, et al. Risk factors for recurrent tuberculosis in England and Wales, 1998–2005. Thorax. 2010;65(4):310–4.CrossRef
9.
go back to reference Jiang H, Zhang G, Yin J, et al. Assessment of Strategies and Epidemiological Characteristics of Tuberculosis in Henan Province, China: Observational Study. JMIR public health and surveillance 2021;7(1): e24830.CrossRef Jiang H, Zhang G, Yin J, et al. Assessment of Strategies and Epidemiological Characteristics of Tuberculosis in Henan Province, China: Observational Study. JMIR public health and surveillance 2021;7(1): e24830.CrossRef
10.
go back to reference Jiang H, Liu M, Zhang Y, et al. Changes in Incidence and Epidemiological Characteristics of Pulmonary Tuberculosis in Mainland China, 2005-2016. JAMA Network Open. 2021; 4(4): e215302. Jiang H, Liu M, Zhang Y, et al. Changes in Incidence and Epidemiological Characteristics of Pulmonary Tuberculosis in Mainland China, 2005-2016. JAMA Network Open. 2021; 4(4): e215302.
12.
go back to reference Millet JP, Shaw E, Orcau A, et al. Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse? PLoS ONE. 2013;8(6): e64898.CrossRef Millet JP, Shaw E, Orcau A, et al. Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse? PLoS ONE. 2013;8(6): e64898.CrossRef
13.
go back to reference Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11(8):828–37.PubMed Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11(8):828–37.PubMed
14.
go back to reference Dobler CC, Crawford AB, Jelfs PJ, et al. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33(1):160–7.CrossRef Dobler CC, Crawford AB, Jelfs PJ, et al. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33(1):160–7.CrossRef
15.
go back to reference Korhonen V, Soini H, Vasankari T, et al. Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study. BMC Infect Dis. 2017;17(1):721.CrossRef Korhonen V, Soini H, Vasankari T, et al. Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study. BMC Infect Dis. 2017;17(1):721.CrossRef
16.
go back to reference Kim L, Moonan PK, Yelk Woodruff RS, et al. Epidemiology of recurrent tuberculosis in the United States, 1993–2010. Int J Tuberc Lung Dis. 2013;17(3):357–60.CrossRef Kim L, Moonan PK, Yelk Woodruff RS, et al. Epidemiology of recurrent tuberculosis in the United States, 1993–2010. Int J Tuberc Lung Dis. 2013;17(3):357–60.CrossRef
18.
go back to reference Yang C, Lu L, Warren JL, et al. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis. 2018;18(7):788–95.CrossRef Yang C, Lu L, Warren JL, et al. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis. 2018;18(7):788–95.CrossRef
19.
go back to reference Kim L, Moonan PK, Heilig CM, et al. Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis. 2016;20:49–56.CrossRef Kim L, Moonan PK, Heilig CM, et al. Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis. 2016;20:49–56.CrossRef
20.
go back to reference Pettit AC, Kaltenbach LA, Maruri F, et al. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011;15(7):906–11.CrossRef Pettit AC, Kaltenbach LA, Maruri F, et al. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011;15(7):906–11.CrossRef
21.
go back to reference Datiko DG, Lindtjorn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study. BMC Public Health. 2009;9(1):1–5.CrossRef Datiko DG, Lindtjorn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study. BMC Public Health. 2009;9(1):1–5.CrossRef
22.
go back to reference Picon PD, Bassanesi SL, Caramori ML, et al. Risk factors for recurrence of tuberculosis. J Bras Pneumol. 2007;33(5):572–8.CrossRef Picon PD, Bassanesi SL, Caramori ML, et al. Risk factors for recurrence of tuberculosis. J Bras Pneumol. 2007;33(5):572–8.CrossRef
23.
go back to reference Austin JF, Dick JM, Zwarenstein M. Gender disparity amongst TB suspects and new TB patients according to data recorded at the South African institute of medical research laboratory for the Western Cape Region of South Africa. Int J Tuberc Lung Dis. 2004;8(4):435–9.PubMed Austin JF, Dick JM, Zwarenstein M. Gender disparity amongst TB suspects and new TB patients according to data recorded at the South African institute of medical research laboratory for the Western Cape Region of South Africa. Int J Tuberc Lung Dis. 2004;8(4):435–9.PubMed
24.
go back to reference Boum Y II, Atwine D, Orikiriza P, et al. Male gender is independently associated with pulmonary tuberculosis among sputum and non-sputum producers people with presumptive tuberculosis in Southwestern Uganda. BMC Infect Dis. 2014;14:638.CrossRef Boum Y II, Atwine D, Orikiriza P, et al. Male gender is independently associated with pulmonary tuberculosis among sputum and non-sputum producers people with presumptive tuberculosis in Southwestern Uganda. BMC Infect Dis. 2014;14:638.CrossRef
25.
go back to reference Lawson L, Lawson JO, Olajide I, et al. Sex differences in the clinical presentation of urban Nigerian patients with pulmonary tuberculosis. West Afr J Med. 2008;27(2):82–6.PubMed Lawson L, Lawson JO, Olajide I, et al. Sex differences in the clinical presentation of urban Nigerian patients with pulmonary tuberculosis. West Afr J Med. 2008;27(2):82–6.PubMed
26.
go back to reference Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.CrossRef Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.CrossRef
27.
go back to reference Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7): e238.CrossRef Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7): e238.CrossRef
28.
go back to reference Nguyen MV, Jenny-Avital ER, Burger S, et al. Clinical and radiographic manifestations of sputum culture-negative pulmonary tuberculosis. PLoS ONE. 2015;10(10): e0140003.CrossRef Nguyen MV, Jenny-Avital ER, Burger S, et al. Clinical and radiographic manifestations of sputum culture-negative pulmonary tuberculosis. PLoS ONE. 2015;10(10): e0140003.CrossRef
29.
go back to reference Sonnenberg P, Murray J, Glynn JR, et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358(9294):1687–93.CrossRef Sonnenberg P, Murray J, Glynn JR, et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358(9294):1687–93.CrossRef
30.
go back to reference Achkar JM, Jenny-Avital ER. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J Infect Dis. 2011;204(suppl 4):S1179–86.CrossRef Achkar JM, Jenny-Avital ER. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J Infect Dis. 2011;204(suppl 4):S1179–86.CrossRef
31.
go back to reference Caminero JA, Pena MJ, Campos-Herrero MI, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med. 2001;163:717–20.CrossRef Caminero JA, Pena MJ, Campos-Herrero MI, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med. 2001;163:717–20.CrossRef
32.
go back to reference Lu LL, Smith MT, Yu KKQ, et al. IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure. Nat Med. 2019;25(6):977–87.CrossRef Lu LL, Smith MT, Yu KKQ, et al. IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure. Nat Med. 2019;25(6):977–87.CrossRef
Metadata
Title
Epidemiology of recurrent pulmonary tuberculosis by bacteriological features of 100 million residents in China
Authors
Hui Jiang
Jinfeng Yin
Fangchao Liu
Yuxia Yao
Chao Cai
Jiying Xu
Lijun Zheng
Chendi Zhu
Junnan Jia
Xu Gao
Wangli Xu
Weimin Li
Guolong Zhang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07622-w

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue